{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T16:03:40Z","timestamp":1769961820326,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109745","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T12:45:14Z","timestamp":1674650714000},"page":"109745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Toosendanin inhibits osteoclast formation and alleviate postmenopausal osteoporosis by regulating the p38 signaling pathway"],"prefix":"10.1016","volume":"116","author":[{"given":"Tingting","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxiao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell. Mol. Biol. Lett"},{"key":"10.1016\/j.intimp.2023.109745_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116538","article-title":"The origins and formation of bone-resorbing osteoclasts","volume":"164","author":"Elson","year":"2022","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.intimp.2023.109745_b0015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.109745_b0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2014.05.034","article-title":"Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways","volume":"449","author":"He","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2023.109745_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103004","article-title":"Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109745_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724256","article-title":"Cimifugin Suppresses NF-\u03baB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109745_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172550","article-title":"Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-\u03baB, ERK, and JNK signaling pathways","volume":"859","author":"Yin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109745_b0040","doi-asserted-by":"crossref","first-page":"42748","DOI":"10.1038\/srep42748","article-title":"Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.109745_b0045","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3892\/ijo.2017.4139","article-title":"Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC-7901 cells partly via miR-200a-mediated downregulation of \u03b2-catenin pathway","volume":"51","author":"Wang","year":"2017","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.intimp.2023.109745_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2018.03.022","article-title":"Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor","volume":"152","author":"Kai","year":"2018","journal-title":"Biochem. Pharmacol"},{"issue":"5","key":"10.1016\/j.intimp.2023.109745_b0055","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3892\/ijo.2015.3157","article-title":"Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"47","author":"Wang","year":"2015","journal-title":"Int. J. Oncol"},{"issue":"47","key":"10.1016\/j.intimp.2023.109745_b0060","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1038\/onc.2017.270","article-title":"Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2018.09.093","article-title":"Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells","volume":"505","author":"Zhou","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109745_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.942049","article-title":"Differential Gene Analysis of Trastuzumab in Breast Cancer Based on Network Pharmacology and Medical Images","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Physiol"},{"key":"10.1016\/j.intimp.2023.109745_b0075","doi-asserted-by":"crossref","first-page":"1011561","DOI":"10.3389\/fphar.2022.1011561","article-title":"Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.intimp.2023.109745_b0080","article-title":"A novel prognostic 6-gene signature for osteoporosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0085","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1016\/j.intimp.2023.109745_b0090","article-title":"Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.intimp.2023.109745_b0095","doi-asserted-by":"crossref","DOI":"10.3791\/53936-v","article-title":"Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation","author":"Amend","year":"2016","journal-title":"J. Vis. Exp. (110)"},{"issue":"6937","key":"10.1016\/j.intimp.2023.109745_b0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.109745_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101754","article-title":"Osteoporosis in 2022 Care gaps to screening and personalised medicine","author":"Curtis","year":"2022","journal-title":"Best. Pract. Res. Clin. Rheumatol"},{"issue":"10329","key":"10.1016\/j.intimp.2023.109745_b0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet. (London,. England)"},{"key":"10.1016\/j.intimp.2023.109745_b0115","first-page":"e1","article-title":"Pharmacological management of osteoporosis in postmenopausal women: The current state of the art","volume":"26","author":"Gatti","year":"2019","journal-title":"Journal. of. population. therapeutics. and. clinical. pharmacology. =. Journal. de. la. therapeutique. des. populations. et. de. la. pharmacologie. clinique"},{"key":"10.1016\/j.intimp.2023.109745_b0120","doi-asserted-by":"crossref","unstructured":"F. Migliorini, G. Colarossi, A. Baroncini, J. Eschweiler, M. Tingart, N. Maffulli, Pharmacological management of postmenopausal osteoporosis: a level I evidence based expert opinion, Expert Rev. Clin. Pharmacol. (2020).","DOI":"10.1080\/17512433.2021.1851192"},{"key":"10.1016\/j.intimp.2023.109745_b0125","series-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","article-title":"Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review","author":"Querrer","year":"2020"},{"issue":"4","key":"10.1016\/j.intimp.2023.109745_b0130","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-22-0574","article-title":"EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management","volume":"187","author":"Reid","year":"2022","journal-title":"Eur. J. Endocrinol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.55729\/2000-9666.1010","article-title":"Teriparatide Associated Late Hypercalcemia: A Report of Two Cases and Literature Review","volume":"12","author":"Milosavljevic","year":"2022","journal-title":"J. Community. Hosp. Intern. Med. Perspect"},{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos. Int"},{"issue":"11","key":"10.1016\/j.intimp.2023.109745_b0145","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol"},{"issue":"4","key":"10.1016\/j.intimp.2023.109745_b0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","article-title":"Recent advances in osteoclast biology","volume":"149","author":"Ono","year":"2018","journal-title":"Histochem. Cell. Biol"},{"key":"10.1016\/j.intimp.2023.109745_b0155","doi-asserted-by":"crossref","first-page":"6910312","DOI":"10.1155\/2020\/6910312","article-title":"RANKL\/RANK\/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling","volume":"2020","author":"Tobeiha","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.intimp.2023.109745_b0160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2023.109745_b0165","doi-asserted-by":"crossref","first-page":"e24780","DOI":"10.1371\/journal.pone.0024780","article-title":"Erk1 positively regulates osteoclast differentiation and bone resorptive activity","volume":"6","author":"He","year":"2011","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.intimp.2023.109745_b0170","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1359\/jbmr.080211","article-title":"JNK\/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts","volume":"23","author":"Ikeda","year":"2008","journal-title":"J. Bone. Miner. Res"},{"issue":"11","key":"10.1016\/j.intimp.2023.109745_b0175","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","article-title":"Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL","volume":"13","author":"Huang","year":"2006","journal-title":"Cell. Death. Differ"},{"issue":"2","key":"10.1016\/j.intimp.2023.109745_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41419-019-1353-3","article-title":"TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment","volume":"10","author":"Liao","year":"2019","journal-title":"Cell. Death. Dis"},{"key":"10.1016\/j.intimp.2023.109745_b0185","doi-asserted-by":"crossref","first-page":"45964","DOI":"10.1038\/srep45964","article-title":"p38\u03b1 MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner","volume":"7","author":"Cong","year":"2017","journal-title":"Sci. Rep"},{"issue":"7","key":"10.1016\/j.intimp.2023.109745_b0190","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1142\/S0192415X2150083X","article-title":"Toosendanin Shows Potent Efficacy Against Human Ovarian Cancer through Caspase-Dependent Mitochondrial Apoptotic Pathway","volume":"49","author":"Wang","year":"2021","journal-title":"Am. J. Chin. Med"},{"issue":"1","key":"10.1016\/j.intimp.2023.109745_b0195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12935-021-02186-2","article-title":"Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer. Cell. Int"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:10:02Z","timestamp":1719231002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"alternative-id":["S1567576923000681"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109745","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toosendanin inhibits osteoclast formation and alleviate postmenopausal osteoporosis by regulating the p38 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109745"}}